BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations
- PMID: 8875986
BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations
Abstract
BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot spots have never been detected in BRCA1 cDNA. Some mutations have been reported several times whereas some others appear to be population-related. In this study a group of 36 Italian families were analysed for BRCA1 germline mutations. All of them were screened by allele-specific oligonucleotide hybridization (ASO) for three recurrent mutations (185delAG, 5382insC, nt332-T>G). Twenty families, selected because of their high risk of carrying BRCA1 mutations, were subjected to analysis of the entire coding sequence of the gene. A total of eight mutations were found. ASO screening demonstrated only one known mutation in one patient, whereas cycle sequencing revealed five new mutations. Three of these new mutations were frameshifts: one occurred in exon 11 (1499insA), one in exon 16 (4873delCA) and one in the splice site of exon 3 (252delAAgt). Two were missense mutations (Cys64Arg; Asn158Tyr). The same frameshift mutation, 1499insA, was detected in three unrelated families. Haplotype analysis supported the hypothesis that two of these families may have had common ancestors, whereas in the third family the analysis was uninformative. BRCA1 germline mutations were found in one out of two families with ovarian cancer, in five out of eight families with breast-ovarian cancer, and in two out of 11 families with breast cancer. All three families with 1499insA mutations included at least one case of ovarian cancer. The majority of the ovarian cancers (4/5) associated with detectable BRCA1 germline mutations were of serous histotype.
Similar articles
-
The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.Neoplasma. 2007;54(2):137-42. Neoplasma. 2007. PMID: 17319787
-
[Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].Ann Acad Med Stetin. 2003;49:27-43. Ann Acad Med Stetin. 2003. PMID: 15552838 Polish.
-
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27. Breast Cancer Res Treat. 2006. PMID: 16261400
-
Inherited susceptibility to breast cancer.Cancer Surv. 1993;18:95-113. Cancer Surv. 1993. PMID: 8013003 Review.
-
[Familial breast cancer].Nihon Rinsho. 1995 Nov;53(11):2764-8. Nihon Rinsho. 1995. PMID: 8538041 Review. Japanese.
Cited by
-
BRCA1 and BRCA2 mutations in central and southern Italian patients.Breast Cancer Res. 2000;2(4):307-10. doi: 10.1186/bcr72. Epub 2000 Mar 31. Breast Cancer Res. 2000. PMID: 11056688 Free PMC article.
-
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Biomed Res Int. 2013;2013:928562. doi: 10.1155/2013/928562. Epub 2013 Nov 7. Biomed Res Int. 2013. PMID: 24312913 Free PMC article. Review.
-
The genetics of inherited breast cancer.J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):365-76. doi: 10.1023/a:1018779830743. J Mammary Gland Biol Neoplasia. 1998. PMID: 10819531 Review.
-
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy.Cancers (Basel). 2021 Jan 30;13(3):532. doi: 10.3390/cancers13030532. Cancers (Basel). 2021. PMID: 33573335 Free PMC article.
-
Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Oncologist. 2016 Jul;21(7):832-9. doi: 10.1634/theoncologist.2015-0416. Epub 2016 Jun 10. Oncologist. 2016. PMID: 27286788 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous